Sustained remission with methotrexate monotherapy after 22-week induction treatment with TNF-alpha inhibitor and methotrexate in early psoriatic arthritis: an open-label extension of a randomized placebo-controlled trial

BACKGROUND: If TNF inhibitors are initiated in the early stages of psoriatic arthritis, this could potentially modulate disease and therefore allow us to discontinue the TNF inhibitor after achieving remission. OBJECTIVE: To investigate whether remission induced by tumour necrosis factor alpha inhib...

Descripción completa

Detalles Bibliográficos
Autores principales: de Jong, Henriëtte M. Y., van Mens, Leonieke J. J., Nurmohamed, Michael T., Kok, Marc R., van Kuijk, Arno W. R., Baeten, Dominique L. P., van de Sande, Marleen G. H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6744710/
https://www.ncbi.nlm.nih.gov/pubmed/31521192
http://dx.doi.org/10.1186/s13075-019-1998-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6744710/
https://www.ncbi.nlm.nih.gov/pubmed/31521192
http://dx.doi.org/10.1186/s13075-019-1998-4

Ejemplares similares